Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with <i>BRCA</i> mutation and/or maintenance therapy-Reference-Cited by-同舟云学术

Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy

Published:2024 Issue: Volume:35 Page:
ISSN:2005-0380
Container-title:Journal of Gynecologic Oncology
language:en
Short-container-title:J Gynecol Oncol

Author:

Lee Young Joo¹^ORCID,Shin Yoon Kyung²^ORCID,Kim Nae Ry³^ORCID,Kim Se Ik⁴^ORCID,Lee Yoo-Young⁵^ORCID,Park Jeong-Yeol²^ORCID,Kim Jae-Weon⁴^ORCID,Cho Hyun-Woong³^ORCID,Lee Jung-Yun¹^ORCID

Affiliation:

1. Department of Obstetrics and Gynecology, Institute of Women’s Life Medical Science, Yonsei University College of Medicine, Seoul, Korea.

2. Department of Obstetrics and Gynecology, Asan Medical Center, Ulsan University Medical School, Seoul, Korea.

3. Department of Obstetrics and Gynecology, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea.

4. Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, Korea.

5. Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

Publisher

XMLink

Link

https://ejgo.org/pdf/10.3802/jgo.2024.35.e73

Reference27 articles.

1. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy

2. Cancer statistics, 2022

3. Worldwide Burden, Risk Factors, and Temporal Trends of Ovarian Cancer: A Global Study

4. Clinical Impact of Natural Killer Group 2D Receptor Expression and That of Its Ligand in Ovarian Carcinomas: A Retrospective Study

5. The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian Cancer